FDA Clears Olympus' Narrow Band Imaging® (NBI) for Effective Targeting of Bladder Cancer Biopsies and Improved Visualization of Tumor Margins

December 15, 2014

Studies show NBI visualizes Non-Muscle-Invasive Bladder Cancer (NMIBC) lesions in additional 17 percent of patients and 24 percent additional tumors – a turning point for identifying the c

  Archived Releases

  2014 releases

  2013 releases

  2012 releases

  2011 releases

  2010 releases

  2009 releases

  2008 releases

  2007 releases

  2006 releases

  2005 releases

  2004 releases

  2003 releases

  2002 releases

  2001 releases

  2000 releases

  1999 releases


Consumer Products |  Diagnostic Systems |  Medical Systems |  Microscopes & Imaging Systems
© 2014 Olympus America Inc.
Privacy Statement
Terms of Use